About Dr. Jaspriya Bal

  • Home
  • About Dr. Jaspriya Bal
About Dr. Jaspriya Bal

The Journey

With years of clinical experience and research excellence, Dr. Jaspriya Bal has emerged as a distinguished figure in Nuclear Medicine. Her work integrates advanced diagnostic imaging (PET/CT) with targeted molecular therapies to treat complex cancers with precision and compassion.

image
image

Summary

Disciplined and confident nuclear medicine physician with around 15 years experience in hospital and clinical settings. Innovative and progressive nuclear medicine physician, selfdriven, result oriented who enjoys working with timelines while managing variety of assignments.

Professional Position & Employment Senior Consultant, since June 2017 Department of Nuclear Medicine and PET-CT, Max Super Specialty Hospital, Saket, Delhi Currently performing around 700 diagnostic & around 15 therapeutic nuclear medicine procedures per month

Membership and Affiliation

  • Life member of Society of Nuclear Medicine (India) (SNMI)
  • Life member of Association of Nuclear Medicine Physicians of India (ANMPI)
  • Member of Indian thyroid society (ITS)
  • Indian Ambassador of Oncidium Foundation For Theranostics and RLTconnect
  • Member of Society of Nuclear Medicine and Molecular Imaging (SNMMI)
  • Member of American College of Nuclear Medicine (ACNM)
  • Member of World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
  • Member of WE (women empowerment group) of European Association of Nuclear Medicine
  • Member of American Society of Nuclear Cardiology (ASNC)
  • Life Member of European Society of Medical Oncologists (ESMO)
image
Testimonials

Featured Case Stories

Professional Position & Employment

  • Role of F-18 FDG in diagnosis of tumor thrombus” in Society of Nuclear Medicine conference at Jaipur, 2009.
  • Paper presentation on “Comparative analysis of 18F-NaF, 18F-FDG and Cocktail 18FNaF/18F-FDG PET/CT for evaluation of malignancy” in Society of Nuclear Medicine conference at PGI Chandigarh,2010.
  • Comparison of F-18 FDG and C-11 Methionine PET/CT for demonstration of subependymal deposit in a treated case of glioblastoma multiforme-case report.
  • Poster presentation on Comparative evaluation of C-11 Methionine (MET-PET) and F-18 flurodeoxyglucose (FDG) PET/CT for detection of recurrent brain tumors” in Society of Nuclear Medicine conference at PGI Chandigarh,2010.
  • Research topic and thesis on carcinoma parathyroid, Hodgkin’s & Non Hodgkin’s lymphoma correlation with imaging (Current & Ongoing research)
  • Role of F-18 FDG PET-CT in evaluation of bone marrow involvement in Lymphomas- Indian Cancer Congress, Nov 2014
  • Palliative chemotherapy (CT) with or without cetuximab (CTX) in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): An Indian retrospective analysis, November 2018, Annals of Oncolog 29(suppl_9
  • Utility of Gallium-68 PSMA PET/CT scan for staging and treatment of prostate cancer in contemporary era: Study from a tertiary care cancer centre in a developing country; November 2018 Annals of Oncolog 29(suppl_9)
  • Clinicoradiological Profile and Treatment Outcomes in Prostate Cancer at a Tertiary Care Cancer Center in India March 2020 Indian Journal of Medical and HYPERLINK Oncology 41(2):187
  • Case report- Primary hyperparathyroidism with Brown tumors masquerading skeletal metastases – Role of functional imaging in diagnosis and management; October 2019 Journal of Clinical and Translational Endocrinology Case Reports
  • All That Lights-Up is not Lymphoma October 2019 Indian Journal of HYPERLINK and Blood Transfusion 36(3):1-2
  • Pleural Mesothelioma with Peritoneal Involvement: Diagnosed on 18F-FDG Positron Emission Tomography/Computed Tomography; Indian Journal of Respiratory Medicine, Volume 8
  • Accuracy of Ga68PSMA PET-CT in detecting lymph nodal metastastses in intermediate to high risk Adenocarcinoma prostate at initial evaluation prior to radical prostatectomy and correlation with final histopathology- A retrospective analysis, Journal of Nuclear Medicine June 2023, 64 (supplement 1) P175;
  • A Rare Case of Renal Malakoplakia Incidentally Detected on 18F-FDG PET/CT in a Patient With Concomitant Breast Cancer and Lymphoma; Ritwik Wakankar 1, Jaspriya Bal, Kanchan Sharma, Pankaj Dougall; Clin Nucl Med. 2024 Jun 3.doi:10.1097.
  • F18 FDG Imaging in a Rare case of Solitary Primary Iliac Bone Lymphoma; Ritwik Wakankar; Jaspriya Bal, Pankaj Dougall; Indian Journal of Hematolgy and Blood Transfusion; 26/August/2024
  • Paraneoplastic Proliferative Myositis on 18F-FDG PET/CT. Wakankar, Ritwik MD; Bal, Jaspriya DRM; Dougall, Pankaj DRM, FICNM. Clinical Nuclear Medicine, October 30, 2024.
  • Authored/ Co-authored 9 posters for Annual European Association Nuclear Medicine Congress, Hamburg, 2024